Popular Weight Loss Drug Zepbound Gains FDA Approval to Treat Sleep Apnea
23 December 2024 at 10:05
The FDA has approved Eli Lilly's Zepbound to treat moderate to severe obstructive sleep apnea in adults with obesity.
The FDA has approved Eli Lilly's Zepbound to treat moderate to severe obstructive sleep apnea in adults with obesity.
